131 related articles for article (PubMed ID: 1332690)
21. Activation of M-phase-specific histone H1 kinase by modification of the phosphorylation of its p34cdc2 and cyclin components.
Pondaven P; Meijer L; Beach D
Genes Dev; 1990 Jan; 4(1):9-17. PubMed ID: 2155162
[TBL] [Abstract][Full Text] [Related]
22. p34cdc2 kinase activity is maintained upon activation of the replication checkpoint in Schizosaccharomyces pombe.
Knudsen KE; Knudsen ES; Wang JY; Subramani S
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8278-83. PubMed ID: 8710861
[TBL] [Abstract][Full Text] [Related]
23. Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells.
Terada N; Lucas JJ; Gelfand EW
J Immunol; 1991 Jul; 147(2):698-704. PubMed ID: 1906503
[TBL] [Abstract][Full Text] [Related]
24. Negative regulation of histone H1 kinase expression by mimosine, a plant amino acid.
Feldman ST; Schönthal A
Cancer Res; 1994 Jan; 54(2):494-8. PubMed ID: 8275487
[TBL] [Abstract][Full Text] [Related]
25. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells.
Kiyokawa H; Ngo L; Kurosaki T; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901
[TBL] [Abstract][Full Text] [Related]
26. Chromosome condensation induced by fostriecin does not require p34cdc2 kinase activity and histone H1 hyperphosphorylation, but is associated with enhanced histone H2A and H3 phosphorylation.
Guo XW; Th'ng JP; Swank RA; Anderson HJ; Tudan C; Bradbury EM; Roberge M
EMBO J; 1995 Mar; 14(5):976-85. PubMed ID: 7889943
[TBL] [Abstract][Full Text] [Related]
27. Control of cell cycle entry and progression in mitogen-stimulated human B lymphocytes.
Takase K; Terada N; Lucas JJ; Gelfand EW
J Cell Physiol; 1995 Feb; 162(2):246-55. PubMed ID: 7529768
[TBL] [Abstract][Full Text] [Related]
28. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.
Arbogast A; Boutet S; Phelouzat MA; Plastre O; Quadri R; Proust JJ
Cell Immunol; 1999 Oct; 197(1):46-54. PubMed ID: 10555995
[TBL] [Abstract][Full Text] [Related]
29. Role of phosphorylation in p34cdc2 activation: identification of an activating kinase.
Solomon MJ; Lee T; Kirschner MW
Mol Biol Cell; 1992 Jan; 3(1):13-27. PubMed ID: 1532335
[TBL] [Abstract][Full Text] [Related]
30. Definition of the roles for iron and essential fatty acids in cell cycle progression of normal human T lymphocytes.
Terada N; Or R; Szepesi A; Lucas JJ; Gelfand EW
Exp Cell Res; 1993 Feb; 204(2):260-7. PubMed ID: 8440323
[TBL] [Abstract][Full Text] [Related]
31. Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites.
Krek W; Nigg EA
EMBO J; 1991 Feb; 10(2):305-16. PubMed ID: 1846803
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic ras stimulates a 96-kDa histone H2b kinase activity in activated Xenopus egg extracts. Correlation with the suppression of p34cdc2 kinase.
Chen CT; Pan BT
J Biol Chem; 1994 Nov; 269(45):28034-43. PubMed ID: 7961738
[TBL] [Abstract][Full Text] [Related]
33. E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products.
Wang HG; Draetta G; Moran E
Mol Cell Biol; 1991 Aug; 11(8):4253-65. PubMed ID: 1830128
[TBL] [Abstract][Full Text] [Related]
34. Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates.
Krek W; Nigg EA
EMBO J; 1991 Nov; 10(11):3331-41. PubMed ID: 1655418
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the cytoplasmic proline-directed protein kinase in proliferative cells and tissues as a heterodimer comprised of p34cdc2 and p58cyclin A.
Hall FL; Braun RK; Mihara K; Fung YK; Berndt N; Carbonaro-Hall DA; Vulliet PR
J Biol Chem; 1991 Sep; 266(26):17430-40. PubMed ID: 1832672
[TBL] [Abstract][Full Text] [Related]
36. Specificity of the polycation-stimulated (type-2A) and ATP,Mg-dependent (type-1) protein phosphatases toward substrates phosphorylated by P34cdc2 kinase.
Agostinis P; Derua R; Sarno S; Goris J; Merlevede W
Eur J Biochem; 1992 Apr; 205(1):241-8. PubMed ID: 1313364
[TBL] [Abstract][Full Text] [Related]
37. Petunia p34cdc2 protein kinase activity in G2/M cells obtained with a reversible cell cycle inhibitor, mimosine.
Perennes C; Qin LX; Glab N; Bergounioux C
FEBS Lett; 1993 Oct; 333(1-2):141-5. PubMed ID: 8224153
[TBL] [Abstract][Full Text] [Related]
38. A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.
Kitagawa M; Higashi H; Takahashi IS; Okabe T; Ogino H; Taya Y; Hishimura S; Okuyama A
Oncogene; 1994 Sep; 9(9):2549-57. PubMed ID: 8058318
[TBL] [Abstract][Full Text] [Related]
39. The retinoblastoma protein physically associates with the human cdc2 kinase.
Hu QJ; Lees JA; Buchkovich KJ; Harlow E
Mol Cell Biol; 1992 Mar; 12(3):971-80. PubMed ID: 1545827
[TBL] [Abstract][Full Text] [Related]
40. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.
Lees JA; Buchkovich KJ; Marshak DR; Anderson CW; Harlow E
EMBO J; 1991 Dec; 10(13):4279-90. PubMed ID: 1756735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
